# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | IC50 | = | 1250 | nM | ALA5138134 | 5.90 | nM | |||
2. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | inhibition | = | 5.87 | % | ALA4808150 | % | Homo sapiens | |||
3. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | inhibition | = | 8.93 | % | ALA4808149 | % | Homo sapiens | |||
4. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Inhibition | = | 28.94 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
5. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | inhibition | = | 0.03 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
6. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541619 | metabolite_detected | Homo sapiens | |||||
7. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541620 | metabolite_detected | Rattus norvegicus | |||||
8. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541621 | metabolite_detected | Homo sapiens | |||||
9. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541622 | metabolite_detected | Rattus norvegicus | |||||
10. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | PB | 0 | ALA3541635 | Active | % | |||||
11. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug excretion | = | 1.5 | % | ALA3539501 | % | ||||
12. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug excretion | = | 0.3 | % | ALA3539500 | % | ||||
13. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug excretion | = | 0.06 | % | ALA3539506 | % | ||||
14. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541623 | metabolite_detected | Homo sapiens | |||||
15. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541624 | metabolite_detected | Rattus norvegicus | |||||
16. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541625 | metabolite_detected | Homo sapiens | |||||
17. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541626 | metabolite_detected | Rattus norvegicus | |||||
18. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541627 | metabolite_detected | Homo sapiens | |||||
19. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541628 | metabolite_detected | Rattus norvegicus | |||||
20. | 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethan-1-one | [14C]-RRx-001 | Drug metabolism | 0 | ALA3541629 | metabolite_detected | Homo sapiens |